SOCIAL QUESTIONS|health|pharmaceutical industry #581844 IATE #3542809 meitil (2S,3S,4S,5S,6S)-6-{[(1S,2S,3S,4R,5R)-3-(aicéitiolocsa)-4-aisídi-6,8-dé-ocsadéchiogl[3.2.1]ocht-2-ail]meitil}-4,5-bis(beinsiolocsa)-3-hiodrocsaiteitrihidri-2H-pioran-2-carbocsaláit Reference Fiontar, DCU ga methyl (2S,3S,4S,5S,6S)-6-{[(1S,2S,3S,4R,5R)-3-(acetyloxy)-4-azido-6,8-dioxabicyclo[3.2.1]oct-2-yl]methyl}-4,5-bis(benzyloxy)-3-hydroxytetrahydro-2H-pyran-2-carboxylateen
SOCIAL QUESTIONS|health|pharmaceutical industry #581305 IATE #3542269 sulfónáit meatán (1S,3S,6S,9S,12S,14R,16R,18S,20R,21R,22S,26R,29S,31R,32S,33R,35R,36S)-20-[(2S)-3-aimíni-2-hiodrocsapróipil]-21-meatocsai-14-meitiléin)-2,19,30,34,37,39,40,41-ochta-ocsanónaciogla[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35]heinteitreacontan-24-ón Reference Fiontar, DCU ga (1S,3S,6S,9S,12S,14R,16R,18S,20R,21R,22S,26R,29S,31R,32S,33R,35R,36S)-20-[(2S)-3-amino-2-hydroxypropyl]-21-methoxy-14-methyl-8,15-bis(methylene)-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35]hentetracontan-24-one methanesulfonateen
SOCIAL QUESTIONS|health|pharmaceutical industry #581315 IATE #3542279 (2R)-3-(beinsiolsulfáinil)-N-[(2S)-1-{[(2S,3S)-1-hiodraisínil-3-meitiol-1-ocsóipeantán-2-il]aimín}-3-(4-hiodrocsaifeinil)-1-ocsaprópán-2-il]-2-{[(4-meitilfeinil)sulfóinil]aimín}própánaimíd Reference Fiontar, DCU ga (2R)-3-(benzylsulfanyl)-N-[(2S)-1-{[(2S,3S)-1-hydrazinyl-3-methyl-1-oxopentan-2-yl]amino}-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-2-{[(4-methylphenyl)sulfonyl]amino}propanamideen
SOCIAL QUESTIONS|health|pharmaceutical industry #581843 IATE #3542808 meitil(1S,2S,3S,4R)-3-[(1S)-1-aimín-2-eitilbúitil]-4-[(treas-bhútocsacarbóinil)aimín]-2-hiodrocsaicioglapeantáncarocsailáit Reference Fiontar, DCU ga methyl (1S,2S,3S,4R)-3-[(1S)-1-amino-2-ethylbutyl]-4-[(tert-butoxycarbonyl)amino]-2-hydroxycyclopentanecarboxylateen